Karen Minder

Background

About Karen Minder

Highly motivated individual with strong oncology/genomic, nursing, clinical, science, research, regulatory and pharmaceutical background. Performance Driven: 2018 winner of the Circle of Excellence AstraZeneca. Oncology Nurse Educator OneKAM Award 2019 Received highest performance ratings 3 years 2016-2019 AstraZeneca 2019 Received Sr Oncology Nurse advancement Top 2016 Recipient of Presidents Award Quintiles. In 2015 and 2014 was awarded,"Clinical Nurse Educator of the Year"​ for maintaining #1 team ranking 3 consecutive quarters in performance metrics. Cross-Functional Approach: Created and implemented genomic/clinical programs for oncology sales and nursing teams. Assisted with launch of new oncology/rare disease products. Participated in training, profiling appropriate accounts and patient types, served as a clinical resource, educated key healthcare professionals on management and administration of products. Expertise Molecular Science and Nursing Oncology : 42 year oncology background and 13 years in biotechnology and translational genomics. Implemented Biomarker Program with Scripps Florida Researchers and Scientists. Strong Oncology/Hematology clinical research/regulatory background: Director of Research Oncology Phase clinical trials. Instituted "Biosafety Level II Recombinant DNA"​ program. Achieved "Institutional Biosafety Committee"​ credentialing, and maintained all oversight requirements mandated by the, National Institute of Health. Committed to Innovation and Quality Outcomes: Cognizant of the future of targeted therapies,and remain committed to applying my educational/clinical background, to innovate strategies that will lead to successful clinical management and improved patient outcomes. Believe in global healthcare for all and that true success in life is,"giving back"​ to those less fortunate. Volunteered for,"Ebola Response Team" in 2015,and was deployed to an, Ebola Treatment Unit in Sierra Leone.